New Video Presentation
Presented in October, 2017 at the Liquid Biopsies and Minimally Invasive Diagnostics conference, this presentation discusses the evolution of liquid biopsy as a clinical option, how it can deliver uniquely informative data, and how the RareCyte platform provides a highly reliable and efficient basis for liquid biopsy sample processing.
Where to See Us
November 8-11, 2017
The RareCyte® platform for identifying rare antigen-specific circulating CD4 and CD8 T cells in Merkel cell carcinoma
Development and application of a 6-channel immunofluorescence assay for investigating PDL1 and IFR1 expression on circulating tumor cells
Dec 5-9, 2017